CELL-BASED WOUND TX TO BE DEVELOPED

An affiliate company of DFB Pharmaceuticals Inc, Healthpoint, Ltd., has signed an exclusive agreement with IsoTis, S.A. to develop and license its patented, biologic, wound-healing technology called Allox.

Related Videos
Related Content

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

New Technology Could Allow Us to Rethink Alopecia Scores

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.